Catalyst Pharmaceuticals Inc. shares outperform competitors on strong trading day

Shares of Catalyst Pharmaceuticals Inc. CPRX,
+ 0.70%
rose 0.70% to $ 4.31 on Thursday, with an all-day gloomy stock market trading session, with the NASDAQ Composite Index COMP,
-0.72%
with 0.72% to 13,865.36 and Dow Jones Industrial Average DJIA,
-0.38%
by 0.38% to 31,493.34. This was the second consecutive earnings day of the stock. Catalyst Pharmaceuticals Inc. closed $ 0.97 below its 52-week high ($ 5.28), which the company reached on February 20th.

The stock outperformed some of its competitors on Thursday, as Johnson & Johnson JNJ,
+ 0.05%
rose 0.05% to $ 165.74, Pfizer Inc. PFE,
-0.95%
it dropped 0.95% to $ 34.56, and Abbott Laboratories ABT,
-1.44%
it fell 1.44% to $ 125.41. The trading volume (1.6 million) remained 394 618 below the 50 day average volume of 2.0 million.

Editor’s Note: This story was automatically generated by Automated Insights using Dow Jones and FactSet data. See our Terms of Use for Market Data.

.Source